A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients with Advanced Solid Tumors and Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2024-10-10
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Chiome Bioscience Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06636435
- Locations
- π―π΅
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
π―π΅Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
π―π΅National Cancer Center Hospital, Chuo, Tokyo, Japan
Β© Copyright 2025. All Rights Reserved by MedPath